Federal Officials Trumpet Record High ACA Enrollment

More than 21.3 million people will be enrolled in an Affordable Care Act during this year’s open enrollment period, Centers for Medicare & Medicaid Services (CMS) announced today. Almost five million more people have signed up for a plan this year than last year, with open enrollment set to continue through the end of January ...

Read More

Walgreens Exploring Sale Of Shields Health Solutions

The specialty pharmacy could be valued at more than $4 billion in a sale, but a deal might slow the U.S. Healthcare segment’s drive toward profitability.

Read More

Newsom Seeks To Delay A Wage Increase For Health Care Workers He’d Approved

California health care workers banking on a state-ordered minimum wage increase later this year might have to wait a little longer. Because of the state’s $38 billion projected budget deficit, Gov. Gavin Newsom on Wednesday said he is seeking changes to a law he signed just three months ago that set the health care industry on a path ...

Read More

Diabetes Patients Lament Drugmaker’s Decision To Discontinue Levemir Insulin

After she was diagnosed at age 48 with Type 1 diabetes, Stacey Silverman muddled through her days with high blood sugar, fatigue and splitting headaches. Taking a long-acting form of insulin called Levemir, one of many types of the hormone on the market, resolved those blood sugar swings. Now the 55-year-old Dallas-area resident worries her ...

Read More

Contradictory Diet Advice Is Making Healthy Eating Even Harder

‘Tis the season of wavering New Year’s resolutions. And 2024 might be an especially hard time to keep to a new diet because there are so many contradictory claims — and so little left on the menu that isn’t being vilified by someone with initials after their name. Mainstream experts are still warning us against ...

Read More

What To Expect From Big Pharma (And Biden’s Push To Lower Drug Prices) In 2024

A look at new legal battles and drug regulations, including the administration’s new initiatives to reduce drug costs and next steps in the FTC’s attempt to address improperly listed patents in the FDA’s Orange Book.

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square